AbbVie Inc. (ABBV) |
|
78.15 0.58 (0.75%)
|
04-22 16:01 |
|
Open: |
77.6 |
Pre. Close: |
77.57 |
|
High:
|
79.1 |
Low:
|
77.5 |
|
Volume:
|
5,201,200 |
Market Cap:
|
115518M |
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
79.137 - 79.615 |
79.615 - 80.073 |
|
Low:
|
76.391 - 76.953 |
76.953 - 77.491 |
|
Close:
|
77.241 - 78.066 |
78.066 - 78.858 |
|
|
|
Technical analysis |
as of: 2019-04-22 4:24:17 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 95.43 One year: 98.96 |
| Support: |
Support1: 76.81 Support2: 63.91 |
| Resistance: |
Resistance1: 81.70 Resistance2: 84.73 |
| Pivot: |
81.35  |
| Moving Average: |
MA(5): 78.98 MA(20): 81.05
MA(100): 83.26 MA(250): 89.99 |
| MACD: |
MACD(12,26): -0.47 Signal(9): 0.10 |
| Stochastic oscillator: |
%K(14,3): 10.62 %D(3): 12.21 |
| RSI: |
RSI(14): 37.67 |
| 52-week: |
High: 107.25 Low: 75.77 Change(%): -16.2 |
| Average Vol(K): |
3-Month: 640558 10-Days: 514412 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.ABBV has closed above bottom band by 10.1%. Bollinger Bands are 3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Sat, 20 Apr 2019 14:07:34 Z
3 Cancer Treatment Stocks to Buy in April
Thu, 18 Apr 2019 17:24:33 Z
AbbVie (ABBV) Earnings Expected to Grow: Should You Buy?
Thu, 18 Apr 2019 17:12:39 Z
Can Q1 Earnings Lift Healthcare ETFs Higher?
Thu, 18 Apr 2019 16:25:10 Z
Here Are the Key Takeaways From J&J's Q1 Earnings Report
Wed, 17 Apr 2019 03:07:06 Z
Is TG Therapeutics a Buy?
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Drug Manufacturers - Major |
| Shares Out. (M) |
1480.00 |
| Shares Float (M) |
1470.00 |
|
% Held by Insiders
|
0.09 |
|
% Held by Institutions
|
71.89 |
|
Shares Short (K)
|
22190 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
3.660 |
|
EPS Est. Current Year
|
5.530 |
|
EPS Est. Next Year
|
6.560 |
|
EPS Est. Next Quarter
|
1.440 |
|
Forward EPS
|
8.888 |
|
Book Value (p.s.)
|
-5.710 |
|
PEG Ratio
|
0.98 |
|
Profit Margin
|
17.36 |
|
Operating Margin
|
36.37 |
|
Return on Assets (ttm)
|
11.4 |
|
Return on Equity (ttm)
|
|
|
Qtrly Rev. Growth
|
7.3 |
|
Gross Profit (p.s.)
|
16.919 |
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
9.243 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
13430.00 |
|
Levered Free Cash Flow (M)
|
12400.00 |
Stock Valuations |
|
P/E
|
21.34 |
|
P/E Growth Ratio
|
0.01 |
|
P/BV
|
-13.68 |
|
P/S
|
5439435264.00 |
|
P/CF
|
8.61 |
Dividends & Splits |
|
Dividend
|
3.950 |
|
Dividend Yield
|
0.05 |
|
Dividend Pay Date
|
2019-05-15 |
|
Ex-Dividend Date
|
2019-04-12 |
|
Forward Dividend
|
4.280 |
|
Last Split Date
|
|
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
